Health Topics:
Benign Prostatic Hyperplasia (BPH)
Benign prostatic hyperplasia ( BPH) is one of the most common diseases
to affect men beyond middle age. It becomes more likely as men get
older. Since the number of men reaching a mature age is increasing,
so are the number of cases of BPH. Today, only 20% of patients with
BPH receive surgery to treat their problem. The remainder are often
managed by "Watchful Waiting." The majority of these "watchful
waiting" patients will require medication in the future as
their condition worsens.
BPH is rarely life-threatening. The symptoms of BPH are: frequency
(the need to urinate often), urgency (the need to urinate immediately),
nocturia (night-time urination), and incomplete bladder emptying.
These can be very bothersome. These symptoms occur slowly and serious
health risks are uncommon. These often impact a patient's quality
of life.
Growth and development of the prostate is affected by the male
hormone testosterone. BPH is usually a slowly developing condition.
This is not, however, always accompanied by a worsening of symptoms.
As BPH progresses, the normal prostatic tissue is compressed more
and more by the surrounding tissue. This then pinches the urethra.
The prostatic urethra becomes less flexible, causing progressive
obstruction of urine flow. Patients complain of hesitancy and a
reduced stream. If bladder emptying becomes too difficult, the patient
may develop urinary retention (urine cannot drain from the bladder).
This intense stretching and strain on the bladder may make recovery
of bladder function difficult, if not impossible.
History and Symptom Assessment
BPH is characterized by many obstructive and irritating symptoms,
often referred to as lower urinary tract symptoms (LUTS). Symptoms
include:
|
Obstructive symptoms
-
Hesitancy (stop-and-go stream)
-
Weak stream
-
Straining to pass urine
-
Prolonged urination
-
Feeling of incomplete bladder emptying
-
cute urinary retention (urine is trapped in the bladder)
|
Irritative symptoms
-
Urgency
-
Frequency
-
Nocturia
-
Urge incontinence
|
Symptoms can be assessed by means of the IPSS, (International Prostate
Symptoms Score) or the AUA (American Urologic Association) symptoms
score index. The physical examination is done by a digital rectal
examination (DRE) on patients with BPH. DRE provides useful information
about the size, consistency, and limits of the prostate. An analysis
of the urine is done, either by dipstick or microscopic examination.
A serum creatinine ( blood test) is used to assess kidney function.
All patients below 75 years of age should also have their Prostatic
Specific Antigen (PSA) levels checked. These tests are useful in
helping to identify patients with prostate cancer.
Treatment Options
Watchful Waiting
Patients with low symptom scores and a normal PSA and DRE can be
considered for watchful waiting. These patients are seen on a yearly
basis. Symptom scores are checked over time. Patients with increasing
symptom scores will progress to other treatments.
Medical Therapy
Medical treatment of BPH should be regarded as an option in its
own right, rather than as merely an interim measure in patients
waiting for surgery. Drugs such as Cardura, Hytrin, and Flomax have
all been shown to increase urine flow rates and improve symptoms
in about 60% of patients with BPH within 4 weeks of treatment. These
drugs work by relaxing the smooth muscle in the prostate. This reduces
obstruction to urine flow without affecting the bladder's ability
to contract. These drugs are given once a day. Most patients start
with a small dose, and gradually increase the dose to improve their
symptoms. Side effects from these drugs are tiredness, dizziness,
and headache, which occur in about 10% of patients. Decreased blood
pressure occurs in only 2-5% of patients and this can be minimized
by lowering the drug dosage.
Other drugs like Proscar act by shrinking the prostate. Proscar
reduces the volume of the prostate by 20-30% in two-thirds of patients.
This results in improvements in both symptoms score and flow rates,
and usually takes about 3-6 months.
Surgical Management of BPH
Surgical treatment is usually indicated for patients who have complications
of BPH, those who have symptoms that are not adequately controlled
by medical therapy or who elect to forego an attempt at medication
for more definitive treatment. These standard surgical operations
are available:
In general, surgical treatments produce the best improvement in
urinary symptoms and urine flow. If compared with medical therapy,
there are more complications with this type of treatment. About
95% of prostatectomies are currently carried out by the TURP procedure.
With this procedure, a scope with a surgical loop is introduced
through the urethra and chips of prostate tissue are cut and removed
through the scope's sheath. The operation can be performed under
spinal, epidural or light general anesthesia. A catheter is left
in place for 36-48 hours after surgery. Symptoms and urine flow
rates are improved in about 70-90% of patients. Complications include
infection, bleeding, incontinence, retrograde ejaculation, and erectile
dysfunction, although these are rare.
Even though BPH is almost never life-threatening, its symptoms
can have a significant effect on the patient's well-being. There
are many ways to treat BPH and with successful treatment, an improvement
in the patient's quality of life can be achieved.
Disclaimer
The information on the Loyola University
Health System (LUHS) Web site is for educational purposes
only. It is presented in summary form in order to impart general
information relating to certain diseases, ailments, physical
conditions and their treatments. The information provided
through the LUHS Web site should not be used for diagnosing
or treating a health problem or a disease, nor is it a substitute
for professional care. Should you have any health-care related
questions or suspect you have a health problem, you should
consult your health care provider. See also Copyright
and Disclaimer.
|
|